Table 2.
Percentage of resistant Staphylococcus strains to indicator antibiotics from inpatient and outpatient departments (2008–2017).
| 2008–2012 | 2013–2017 | |||||
|---|---|---|---|---|---|---|
| Outpatients (%) | Inpatients (%) | Statisticsa | Outpatients (%) | Inpatients (%) | Statisticsa | |
| Penicillin | 94.8 | 96.6 | n.s | 95.2 | 96.9 | n.s |
| Ampicillinb | 10.8 | 12.2 | n.s | 12.4 | 13.7 | n.s |
| Cefoxitinc | 0.6 | 1.9 | n.s | 9.8 | 11.6 | n.s |
| Amikacin | 1.5 | 23.2 | p < 0.001 | 1.1 | 14.2 | p < 0.001 |
| Gentamicin | 4.6 | 23.2 | p = 0.028 | 2.1 | 24.8 | p < 0.001 |
| Azithromycin | 19.5 | 25.8 | p = 0.049 | 32.3 | 33.2 | n.s |
| Clindamycin | 17.9 | 21.9 | n.s | 22.1 | 26.3 | n.s |
| Ciprofloxacin | 9.7 | 35.7 | p < 0.001 | 12.1 | 25.6 | p = 0.042 |
| Doxycycline | 13.3 | 29.8 | p = 0.04 | 4.2 | 30.8 | p < 0.001 |
| Nitrofurantoin | 2.6 | 3.3 | n.s | 0.5 | 3.8 | p = 0.046 |
| SMX/TMPd | 5.6 | 23.2 | p < 0.001 | 1.1 | 27.1 | p < 0.001 |
| Rifampicin | 1.0 | 2.3 | n.s | 3.3 | 4.8 | n.s |
| Vancomycine | 0.0 | 0.0 | n.s | 0.0 | 0.0 | n.s |
| QP/DPf | 0.0 | 0.0 | n.s | 0.0 | 0.0 | n.s |
| Tigecycline | 0.0 | 0.0 | n.s | 0.0 | 0.0 | n.s |
| Linezolid | 0.0 | 0.0 | n.s | 0.0 | 0.0 | n.s |
| Fusidic acid | 0.0 | 0.0 | n.s | 0.0 | 0.0 | n.s |
aComparison of resistance levels among isolates originating from outpatients and inpatients.
bCalculated for S. saprophyticus isolates only.
cRepresent the ratio of MRSA isolates in S. aureus.
dSulfamethoxazole-trimethoprim.
eRepresents the ratio of VISA/VRSA strains.
fQuinpristin/dalfopristin.
n.s.: not significant (p > 0.05).